Hemodialysis, Plea of Availability versus Adequecy Gezira Experience

Mohamed  Elhafiz; Mohamed  El Imam; Alwaleed  A/Gabar; Elhadi  Miskeen

doi:10.52981/sjms.v4i1.919

Mohamed Elhafiz Consultant nephrologist, Gezira Hospital for Renal Disease &Surgery , Sudan
Mohamed El Imam Urologist, department of surgery, University of Gezira, Sudan
Alwaleed A/Gabar University of Gezira, Sudan
Elhadi Miskeen Educational Development & Research Centre (Registrar Obs Gyn, University of Gezira)

DOI: https://doi.org/10.52981/sjms.v4i1.919

Keywords: Gezira, dialysis, ESRD

Abstract

Objectives: This is a prospective cross sectional study carried out in Gezira Hospital for Renal Diseases and Surgery (Sudan) to assess the adequacy of hemodialysis in 206 patients with end stage kidney disease on regular hemodialysis twice per week using.
Methods: Pre and post hemodialysis blood sample were obtained from the study group, spKt/V and urea reduction ratio were calculated.
Results: Mean Kt/v was found to be 1.19 and urea reduction ratio was 59.55%. None of the patients in this study group achieved the National Kidney Foundation Dialysis Outcomes Quality Initiative (K/DOQI) recommendations for adequate hemodialyis, since it requires
three hemodialyis sessions per week and our patients are receiving two sessions per week.
Conclusion: In order to improve the situation herewith we recommended increased number of sessions from two to three times per week and \or increase the duration of hemodialysis session, increase blood flow rate and dialysate flow rate. Moreover, decrease the number of patients on
regular hemodialysis by encouraging the patients to take the other renal replacement therapy (peritoneal dialysis and renal transplantations).

Author Biography

Alwaleed A/Gabar, University of Gezira, Sudan

Assistant Professor of Medicine

References

1.K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1.
2. Renal Physicians Association Working Committee on Clinical Practice Guidelines. Clinical practice guideline on adequacy of hemodialysis. In: Clinical Practice Guideline, Number 1. Washington, DC: Renal Physicians Association; December 1993.
3. Hemodialysis Adequacy Work Group. NKF-DOQI clinical practice guidelines for hemodialysis. Am J Kidney Dis 1997; 30 (suppl 2): S15-S66.
4. Owen WF, Lew NL, Liu Y, et al. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993; 329 (14): 1001-1006.
5. Lowrie EG, Lew NL. The urea reduction ratio (URR): a simple method for evaluating hemodialysis treatment. Contemp Dial Nephrol. 1991; 12:11-20.6. Gotch FA. Kinetic modeling in hemodialysis. In: Nissenson AR, Fine RN, Gentile DE, eds. Clinical Dialysis. 2nd ed. Norwalk, Conn: Appleton & Lange; 1990:118-146.
7. Depner TA. Prescribing Hemodialysis: A Guide to Urea Modeling. Norwell, Mass: Kluwer Academic Publishers; 1991.
8. Hakim RM, Depner TA, Parker TF. Adequacy of hemodialysis. Am J Kidney Dis 1992; 20: 107-123.
9. NKF-K/DOQI Clinical Practice Guidelines for hemodialysis adequacy: update 2000. Am J Kid Dis2001; 37:S7-S64.
10.Owen WF Jr, Lew NL, Liu Y, et al. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993; 329:1001-1006.
11. Gotch, FA, Sargent, JA. A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 1985; 28: 526-534.
12. Laird NM, Berkey CS, Lowrie EG. Modeling success or failure of dialysis therapy: the National Cooperative Dialysis Study. Kidney Int 1983: 23 (Suppl 13) S101-S107.
13. Parker TF, Laird NM, Lowrie EG. Comparison of the study groups in the National Cooperative Dialysis Study and a description of morbidity, mortality, and patient withdrawal. Kidney Int 1983: 23 (Suppl13); S42-S49. 14. 2005 Annual Report: ESRD clinical performance measures project. Am J Kidney Dis Suppl 2006; 48:S24.
15. Hecking E, Bragg-Gresham JL, Rayner HC, et al. Haemodialysis prescription, adherence and nutritional indicators in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2004; 19:100-107.
16. McClellan WM, Soucie JM, Flanders WD. Mortality in end-stage renal disease is associated with facility-to-facility differences in the adequacy of hemodialysis. J Am Soc Nephrol 1998; 9: 1940-1947.
17. Li Z, Lew NL, Lazarus JM, Lowrie EG. Comparing the urea reduction ratio and the urea product as outcome-based measures of hemodialysis dose. Am J Kidney Dis 2000; 35:598-605.
18. Chertow GM, Owen WF, Lazarus JM, et al. Exploring the reverse J-shaped curve between urea reduction ratio and mortality. Kidney Int 1999; 56:1872-1878.
19. Cheung AK, et al. Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study. J Am Soc Nephrol 2003; 14 (12): 3251-3263.
20. Gotch FA: Kinetic modeling in hemodialysis, in Clinical Dialysis, 2nd Ed, edited by Nissenson AR, Fine RN, Gentile DE, Norwalk CT. Appleton & Lange, 1990, pp 118-146